Today, Nature Communications published a long-expected Matters Arising in response to a 2021 paper in the same journal: “A new hypothesis for the origin of Amazonian Dark Earths“. The new paper, involving more than 50 leading scholars involved in research on prehistoric Amazonia, affirms a human origin for the dark earths found throughout the central and eastern Amazon basin.
Amazonian Dark Earths (ADEs) are distinguished by their exceptional fertility and richness of archaeological remains. Evidently produced by various kinds of human activity, including but not limited to manuring, rubbish deposition, and biomass burning, they are a distinctive feature of later indigenous settlement of the Amazon river basin.

The paper synthesises diverse archaeological, palaeoenvironmental, and historic data to demonstrate the human origin of ADEs. Source: Lombardo et al. 2022
For more information see: Lombardo, U., Arroyo-Kalin, M., Schmidt, M. et al. Evidence confirms an anthropic origin of Amazonian Dark Earths. Nat Commun 13, 3444 (2022). https://doi.org/10.1038/s41467-022-31064-2
IMSET Seminar: Exploring the chaîne opératoire of applied long-term human ecodynamics










Innovative Approaches to Doctoral Supervision: Selected Case Studies
3C Event: Research Culture, Community & Canapés-Tuesday 19 May 1-2pm
New chapters published in maternity book on risk
The British Academy European Research Council Grant Support Sessions
Grant Writing Workshops: Master the Art of the Winning Proposal
UKCGE Recognised Research Supervision Programme: New Application Window
Apply now to take part in the 2026 ESRC Festival of Social Science
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease